Table 2.
Two-year PFS and 3-, 5-year OS by risk groups
PCC (%) | CTPF (%) | |
---|---|---|
Two-year PFS | ||
All patients | 89 | 88 |
Low risk | 96 | 88 |
Intermediate/high risk | 67 | 89 |
N2c-N3 | 78 | 88 |
HPV-positive/never smokers | 100 | 90 |
HPV-positive/≤10 pack years | 100 | 89 |
HPV-positive/>10 pack years | 84 | 80 |
HPV-negative | 82 | 100 |
HPV-positive | 92 | 85 |
Three-year OS | ||
All patients | 89 | 92 |
Low risk | 97 | 92 |
Intermediate/high risk | 65 | 89 |
Five-years OS | ||
All patients | 89 | 86 |
Low risk | 97 | 92 |
Intermediate/high risk | NA*a | 66 |
PFS, progression-free survival; OS, overall survival.
All patients either died or were censored before 5 years.